Loading clinical trials...
Loading clinical trials...
Assessment of Advanced Imaging Techniques in the Evaluation and Management of Prostate Cancer
MRI is being increasingly relied upon for detection, staging and management of prostate cancer. In this study patients with risk of prostate cancer will be recommended to have a pelvic MRI prior to the standard biopsy of the prostate and standard treatment of any detected prostate cancer. The results of the MRI will be compared to standard diagnosis techniques to see if cancer can be more accurately detected.
The study team hypothesizes that strategic use of advanced MRI methods will provide a more accurate and less invasive approach for diagnosis and management of prostate cancer. The primary objectives are: 1. To develop advanced MRI methods and optimal MRI protocols for detection, staging, and follow-up of prostate cancer. 2. To evaluate the diagnostic performance of MRI-guided biopsy methods and correlate MRI findings with the pathological grade of cancer. 3. To correlate prostate MRI findings and biopsy results with patient progress and outcomes. 4. To evaluate the diagnostic accuracy of MRI in disease re-classification in patients on active surveillance. Secondary Objectives: 1. To apply computer-aided advanced image analytic techniques (Computer-assisted diagnostics- CAD) to extract MRI features of patient clinical scans that correlate with diagnosis and grade of prostate cancer. 2. To study MRI features of lesions that mimic prostate cancer on imaging eg - chronic prostatitis, post treatment changes. 3. To evaluate the impact of MRI in decision making and choice of treatment by physicians and patients.
Age
40 - 90 years
Sex
MALE
Healthy Volunteers
No
Start Date
August 1, 2017
Primary Completion Date
May 20, 2019
Completion Date
June 20, 2023
Last Updated
March 16, 2023
MRI guided biopsy
DEVICE
TRUS biopsy
PROCEDURE
Lead Sponsor
Case Comprehensive Cancer Center
NCT06842498
NCT05691465
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04550494